The
global
increase
in
the
aging
population
presents
critical
challenges
for
healthcare
systems,
social
security,
and
economic
stability
worldwide.
Although
studies
of
rate
have
increased
more
than
four
times
past
two
decades,
few
integrated
potential
combined
effects
socio-economic,
climatic,
environmental
factors.
Humanities and Social Sciences Communications,
Год журнала:
2024,
Номер
11(1)
Опубликована: Март 15, 2024
Abstract
The
purpose
of
this
research
is
to
identify
and
evaluate
the
technical,
ethical
regulatory
challenges
related
use
Artificial
Intelligence
(AI)
in
healthcare.
potential
applications
AI
healthcare
seem
limitless
vary
their
nature
scope,
ranging
from
privacy,
research,
informed
consent,
patient
autonomy,
accountability,
health
equity,
fairness,
AI-based
diagnostic
algorithms
care
management
through
automation
for
specific
manual
activities
reduce
paperwork
human
error.
main
faced
by
states
regulating
were
identified,
especially
legal
voids
complexities
adequate
regulation
better
transparency.
A
few
recommendations
made
protect
data,
mitigate
risks
regulate
more
efficiently
international
cooperation
adoption
harmonized
standards
under
World
Health
Organization
(WHO)
line
with
its
constitutional
mandate
digital
public
health.
European
Union
(EU)
law
can
serve
as
a
model
guidance
WHO
reform
International
Regulations
(IHR).
PLoS ONE,
Год журнала:
2025,
Номер
20(1), С. e0317379 - e0317379
Опубликована: Янв. 13, 2025
Introduction
Personalised
prevention
offers
a
promising
tool
to
reduce
the
impact
of
non-communicable
diseases,
which
represent
growing
health
burden
worldwide.
However,
support
adoption
this
innovation
it
is
needed
clarify
current
state
available
evidence
in
area.
This
work
aims
provide
an
overview
recent
publications
on
personalised
for
chronic
conditions.
Materials
and
methods
A
scoping
review
scientific
literature
from
Medline,
Scopus,
Web
Science
grey
was
conducted.
Eligible
articles
included
prospective
primary
studies
clinical
practice
directives
preventive
approaches
diseases
published
between
January
2017
December
2023.
The
followed
Arksey-O’Malley
guidelines
PRISMA-ScR
checklist.
Results
We
identified
121
including
60
cohort
61
directives.
extracted
249
approaches,
27%
prevention,
secondary
46%
tertiary
prevention.
In
50%
67
were
studies,
mainly
targeting
cardiovascular
primarily
focused
cancer.
Secondary
66
73%
concerning
breast
Tertiary
116
evenly
distributed
among
two
publication
types
focusing
mostly
cancer
diseases.
Lastly,
most
represented
level
both
research
(54%
41%
respectively).
Conclusions
Our
study
highlights
significant
focus
oncology
past
few
years,
with
numerous
recently
issued
substantial
original
indicating
interest
field.
distribution
across
three
levels
anticipate
challenges
generating
utility
falling
under
Frontiers in Digital Health,
Год журнала:
2024,
Номер
6
Опубликована: Янв. 26, 2024
Introduction
A
digital
twin
is
a
virtual
representation
of
patient's
disease,
facilitating
real-time
monitoring,
analysis,
and
simulation.
This
enables
the
prediction
disease
progression,
optimization
care
delivery,
improvement
outcomes.
Methods
Here,
we
introduce
framework
for
type
2
diabetes
(T2D)
that
integrates
machine
learning
with
multiomic
data,
knowledge
graphs,
mechanistic
models.
By
analyzing
substantial
clinical
dataset,
constructed
predictive
models
to
forecast
progression.
Furthermore,
graphs
were
employed
elucidate
contextualize
multiomic–disease
relationships.
Results
discussion
Our
findings
not
only
reaffirm
known
targetable
components
but
also
spotlight
novel
ones,
unveiled
through
this
integrated
approach.
The
versatile
presented
in
study
can
be
incorporated
into
system,
enhancing
our
grasp
diseases
propelling
advancement
precision
medicine.
Advances in Nutrition,
Год журнала:
2025,
Номер
unknown, С. 100377 - 100377
Опубликована: Янв. 1, 2025
Personalized
Nutrition
(PN)
represents
an
approach
aimed
at
delivering
tailored
dietary
recommendations,
products
or
services
to
support
both
prevention
and
treatment
of
nutrition-related
conditions
improve
individual
health
using
genetic,
phenotypic,
medical,
nutritional,
other
pertinent
information.
However,
current
approaches
have
yielded
limited
scientific
success
in
improving
diets
mitigating
diet-related
conditions.
In
addition,
PN
currently
caters
a
specific
subgroup
the
population
rather
than
having
widespread
impact
on
diet
level.
Addressing
these
challenges
requires
integrating
traditional
biomedical
assessment
methods
with
psycho-behavioral,
novel
digital
diagnostic
for
comprehensive
data
collection,
which
holds
considerable
promise
alleviating
present
shortcomings.
This
not
only
allows
deriving
personalized
goals
("what
should
be
achieved")
but
also
customizing
behavioral
change
processes
("how
bring
about
change").
We
herein
outline
discuss
concept
"Adaptive
Advice
Systems"
(APNASs),
blends
from
three
domains:
1)
biomedical/health
phenotyping;
2)
stable
dynamic
signatures;
3)
food
environment
data.
behavior
are
envisaged
no
longer
based
solely
static
will
adapt
dynamically
in-time
in-situ
individual-specific
To
successfully
integrate
biomedical,
environmental
guidance,
advanced
tools
(e.g.,
sensors)
artificial
intelligence
(AI)-based
essential.
conclusion,
integration
established
paradigms
great
potential
transitioning
its
focus
elite
nutrition
widely
accessible
tool
that
delivers
meaningful
benefits
general
population.
Analytical Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 3, 2025
Early
detection
and
precise
tumor
localization
are
critical
for
improving
treatment
outcomes
enabling
more
targeted
minimally
invasive
therapies
as
biotechnology
evolves.
However,
endogenous
biomarkers
from
early
lesions
face
significant
challenges,
such
short
circulation
times
blood
dilution,
which
hinder
diagnostic
efforts.
In
this
study,
we
present
a
multimodal
nanosensor
specifically
engineered
to
target
cancer
by
responding
CD44
tumor-associated
enzymes
within
the
microenvironment.
Following
systemic
administration,
selectively
accumulates
at
disease
site,
delivering
hexaminolevulinate
(HAL)
produce
protoporphyrin
IX
(PpIX)
synthetic
biomarker,
thus
amplifying
signals
analysis
via
microfluidics-based
device.
Concurrently,
embedded
Gd2O3
nanoclusters
facilitate
visualization
through
magnetic
resonance
imaging
(MRI).
Beyond
diagnosis,
innovative
methodology
supports
monitoring
of
drug
response
assessment
reporter
MRI
imaging.
This
multifunctional
system
addresses
limitations
in
traditional
diagnostics,
typically
rely
on
sequential
biomarker
tests,
followed
Our
approach
enhances
efficiency,
minimizes
need
procedures,
promotes
accurate
personalized
care.